Illumina, Inc. (ILMN) stock
ILMNNasdaqLaboratory Analytical InstrumentsFiscal year ends January 3
Financials through Q3 FY2026, quarter ended Sep 27, 2026Last filing: 10-Q on Oct 30, 2026Score 13/3016% above fair value
$207.01−2.54 (-1.21%)
Close on Nov 13, 2026Market cap $31.30BP/E 35.5Yield –
Illumina total assets
Total assets on the balance sheet at the end of each period.
Illumina's total assets was $6.81B at Sep 27, 2026. For fiscal 2025 it was $6.64B, up 5.4% from the year before. Over ten years it grew 6.1% a year on average. The highest annual figure on record is $15.22B in fiscal 2021.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 28, 2025 | $6.64B | +5.4% |
| FY2024 | Dec 29, 2024 | $6.30B | -37.7% |
| FY2023 | Dec 31, 2023 | $10.11B | -17.5% |
| FY2022 | Jan 1, 2023 | $12.25B | -19.5% |
| FY2021 | Jan 2, 2022 | $15.22B | +100.6% |
| FY2020 | Jan 3, 2021 | $7.59B | +3.7% |
| FY2019 | Dec 29, 2019 | $7.32B | +5.1% |
| FY2018 | Dec 30, 2018 | $6.96B | +32.4% |
| FY2017 | Dec 31, 2017 | $5.26B | +22.8% |
| FY2016 | Jan 1, 2017 | $4.28B | +16.1% |
| FY2015 | Jan 3, 2016 | $3.69B | +10.4% |
| FY2014 | Dec 28, 2014 | $3.34B | +10.6% |
| FY2013 | Dec 29, 2013 | $3.02B | +17.7% |
| FY2012 | Dec 30, 2012 | $2.57B | +16.9% |
| FY2011 | Jan 1, 2012 | $2.20B | +19.4% |
| FY2010 | Jan 2, 2011 | $1.84B | +28.6% |
| FY2009 | Jan 3, 2010 | $1.43B | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 27, 2026 | $6.81B | +10.3% |
| Q2 FY2026 | Jun 28, 2026 | $6.65B | +9.2% |
| Q1 FY2026 | Mar 29, 2026 | $6.56B | +6.1% |
| Q4 FY2025 | Dec 28, 2025 | $6.64B | +5.4% |
| Q3 FY2025 | Sep 28, 2025 | $6.18B | +2.7% |
| Q2 FY2025 | Jun 29, 2025 | $6.09B | +0.1% |
| Q1 FY2025 | Mar 30, 2025 | $6.18B | -38.4% |
| Q4 FY2024 | Dec 29, 2024 | $6.30B | -37.7% |
| Q3 FY2024 | Sep 29, 2024 | $6.01B | -40.6% |
| Q2 FY2024 | Jun 30, 2024 | $6.08B | -48.4% |
| Q1 FY2024 | Mar 31, 2024 | $10.04B | -15.0% |
| Q4 FY2023 | Dec 31, 2023 | $10.11B | -17.5% |
| Q3 FY2023 | Oct 1, 2023 | $10.12B | -10.1% |
| Q2 FY2023 | Jul 2, 2023 | $11.77B | -23.8% |
| Q1 FY2023 | Apr 2, 2023 | $11.81B | -22.7% |
| Q4 FY2022 | Jan 1, 2023 | $12.25B | -19.5% |
| Q3 FY2022 | Oct 2, 2022 | $11.26B | -25.3% |
| Q2 FY2022 | Jul 3, 2022 | $15.45B | +78.1% |
| Q1 FY2022 | Apr 3, 2022 | $15.27B | +74.5% |
| Q4 FY2021 | Jan 2, 2022 | $15.22B | +100.6% |
| Q3 FY2021 | Oct 3, 2021 | $15.06B | +103.4% |
| Q2 FY2021 | Jul 4, 2021 | $8.68B | +19.7% |
| Q1 FY2021 | Apr 4, 2021 | $8.76B | +20.6% |
| Q4 FY2020 | Jan 3, 2021 | $7.59B | +3.7% |
| Q3 FY2020 | Sep 27, 2020 | $7.40B | +4.4% |
| Q2 FY2020 | Jun 28, 2020 | $7.25B | +3.9% |
| Q1 FY2020 | Mar 29, 2020 | $7.26B | -1.7% |
| Q4 FY2019 | Dec 29, 2019 | $7.32B | +5.1% |
| Q3 FY2019 | Sep 29, 2019 | $7.09B | +4.9% |
| Q2 FY2019 | Jun 30, 2019 | $6.97B | +19.2% |
| Q1 FY2019 | Mar 31, 2019 | $7.39B | +33.3% |
| Q4 FY2018 | Dec 30, 2018 | $6.96B | +32.4% |
| Q3 FY2018 | Sep 30, 2018 | $6.76B | +33.9% |
| Q2 FY2018 | Jul 1, 2018 | $5.85B | +20.4% |
| Q1 FY2018 | Apr 1, 2018 | $5.54B | +20.5% |
| Q4 FY2017 | Dec 31, 2017 | $5.26B | +22.8% |
| Q3 FY2017 | Oct 1, 2017 | $5.05B | – |
| Q2 FY2017 | Jul 2, 2017 | $4.86B | – |
| Q1 FY2017 | Apr 2, 2017 | $4.60B | – |
| Q4 FY2016 | Jan 1, 2017 | $4.28B | – |
See a number that looks wrong?